Rising mesothelioma claims and expenses, exceeding projections. That’s the May 22, 2014 financial word from Australia’s James Hardie. An ABC News story is here. This “investors” page for James Hardie includes links to download Hardie’s May 22, 2014 press release, and KPMG’s March 31, 2014 report on expenses  for the James Hardie asbestos trust.


It’s back to Australia. There, an important new appellate court opinion affirms a verdict for a brake mechanic who won a trial court judgment that his mesothelioma was caused by inhalation of chrysotile asbestos fibers from automotive brake linings.  A popular press article is here regarding the plaintiff, John Booth. The appellate opinion is here

Estimates and disclosure of contingent risks are front and center these days in various contexts. Thus, asbestos-specific estimates and disclosures are prominently mentioned in a new  Australian appellate decision in CSR. The opinion was issued at the end of last week, and provides some narrow guidance on solvent schemes of arrangement for companies facing asbestos claiming. A prior post here  describes the

Look to the right under "James Hardie" for prior posts regarding legal issues related to James Hardie’s efforts to use a private foundation to resolve asbestos claims, and related claims against officers and directors that ended in convictions.  Appeals are now in argument for two weeks or so. Popular press articles on the appeal are here and

Back to Australia, asbestos and James Hardie.

As described in this prior post, a rather dry paper by KPMG describes the history of James Hardie and its many intersections with asbestos and asbestos-containing products. That dry look is of course needed and appropriate in the sense that decisions need to be made based on technical information.

There are